Morfinesulfaat Teva (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Morfinesulfaat Teva, is an opioid analgesic presented as an oral formulation for oral use. It is employed to manage moderate to severe acute pain, post‑operative discomfort, and cancer‑related pain in adult patients.

GNH USA supplies Morfinesulfaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements to ensure product integrity across global markets.

Morphine Sulfate is an opioid analgesic used in the management of pain across several clinical settings.

- Moderate to severe acute pain: provides rapid analgesia to reduce pain intensity. - Post‑operative pain: controls postoperative discomfort and facilitates recovery. - Cancer‑related pain: alleviates persistent pain associated with malignant disease.

Morphine Sulfate may be associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Nausea: feeling of queasiness, often accompanied by vomiting. - Drowsiness: increased sleepiness or sedation. - Dizziness: light‑headed sensation, especially upon standing.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Hypotension: significant drop in blood pressure, causing faintness. - Dependence or addiction: development of physical or psychological reliance. - Adrenal insufficiency: rare suppression of adrenal hormone production.

When prescribing Morphine Sulfate, clinicians should consider several safety measures to minimize risk.

- Assess pain severity and opioid tolerance: evaluate patient’s pain level and prior opioid exposure before initiating therapy. - Monitor for respiratory depression: observe breathing rate, especially during dose escalation or in opioid‑naïve patients. - Avoid use in patients with severe respiratory disease: contraindicated in uncontrolled asthma or COPD. - Use caution in renal or hepatic impairment: adjust dosing and monitor organ function. - Store at ambient temperature below 25 °C: keep in original container, protect from moisture and light.

Morphine Sulfate can interact with other medications, altering its effectiveness or safety profile.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression. - MAO inhibitors: risk of severe hypotension and serotonin syndrome. - Anticholinergic agents: increase risk of constipation and urinary retention.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may increase serotonin levels; monitor for serotonin syndrome. - CYP3A4 inhibitors (e.g., erythromycin): can raise morphine plasma concentrations. - Diuretics: may enhance hypotensive effects.